Skip to main content
. 2015 Jun 28;6(18):15842–15856. doi: 10.18632/oncotarget.4683

Figure 2. p53-dependent regulation of CST5 in HCT116 and RKO cancer cells.

Figure 2

A., B. CST5- and C., D. p21-mRNA levels were measured by qPCR analysis at the indicated time points. A., C. HCT116 p53−/− or p53+/+ and B., D. RKO p53+/+ or p53−/− were treated with nutlin-3a or etoposide or the vehicle DMSO. Fold changes represent mean values of triplicate analyses of nutlin-3a/etoposide versus DMSO treated cells normalized to β-actin expression. Error bars represent standard deviations.